(Q36201569)

12 August 2017

1 reference

title

Antifungal combination therapy: clinical potential (English)

1 reference

12 August 2017

John W Baddley

1

1 reference

12 August 2017

Peter G Pappas

series ordinal

2

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

65

1 reference

12 August 2017

issue

11

1 reference

12 August 2017

page(s)

1461-1480

1 reference

Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis

12 August 2017

cites work

1 reference

12 December 2020

Combination therapy in a model of pulmonary aspergillosis

1 reference

12 December 2020

In vitro synergy and antagonism of antifungal agents against yeast-like fungi

1 reference

12 December 2020

Guidelines for treatment of candidiasis

1 reference

12 December 2020

Rationale for combination antifungal therapy

1 reference

12 December 2020

Compounds active against cell walls of medically important fungi

1 reference

12 December 2020

Evaluation of polyene-azole antagonism in liquid cultures of Candida albicans using an automated turbidometric method

1 reference

12 December 2020

Oral azole drugs as systemic antifungal therapy

1 reference

12 December 2020

5-Fluorocytosine antagonizes the action of sterol biosynthesis inhibitors in Candida glabrata

1 reference

12 December 2020

5-fluorocytosine in the treatment of cryptococcal and candida mycoses.

1 reference

12 December 2020

In vitro interaction of fluconazole and amphotericin B administered sequentially against Candida albicans: effect of concentration and exposure time.

1 reference

12 December 2020

In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

1 reference

12 December 2020

Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin

1 reference

12 December 2020

Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

1 reference

12 December 2020

In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans

1 reference

12 December 2020

Amphotericin B: spectrum and resistance

1 reference

12 December 2020

Combination antifungal therapy

1 reference

12 December 2020

Combination Therapy of Experimental Candidiasis, Cryptococcosis and Aspergillosis in Mice

1 reference

12 December 2020

Comparative studies on the postantifungal effect produced by the synergistic interaction of flucytosine and amphotericin B on Candida albicans

1 reference

12 December 2020

Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles.

1 reference

12 December 2020

Amphotericin B: 30 years of clinical experience

1 reference

12 December 2020

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

1 reference

12 December 2020

Mode of action of 5-fluorocytosine

1 reference

12 December 2020

Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia

1 reference

12 December 2020

Synergistic Action of Amphotericin B and 5-Fluorocytosine Against Yeast-Like Organisms

1 reference

12 December 2020

Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology

1 reference

12 December 2020

Therapy of Murine Aspergillosis with Amphotericin B in Combination with Rifampin or 5-Fluorocytosine

1 reference

12 December 2020

In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole

1 reference

12 December 2020

Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism

1 reference

12 December 2020

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

12 December 2020

Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia

1 reference

12 December 2020

Use of amphotericin B with azole antifungal drugs: what are we doing?

1 reference

12 December 2020

The effect of antifungal drugs in combination on the growth of Candida glabrata in solid and liquid media

1 reference

12 December 2020

Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance

1 reference

12 December 2020

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

1 reference

12 December 2020

Candidal meningitis in HIV-infected patients: analysis of 14 cases

1 reference

12 December 2020

Investigational antifungal agents.

1 reference

12 December 2020

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

1 reference

12 December 2020

Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs

1 reference

12 December 2020

A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

12 December 2020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

12 December 2020

Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species

1 reference

12 December 2020

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

12 December 2020

Amphotericin B with and without itraconazole for invasive aspergillosis: A three-year retrospective study

1 reference

12 December 2020

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group

1 reference

12 December 2020

Combination Therapy of Experimental Histoplasmosis and Cryptococcosis with Amphotericin Band Ketoconazole

1 reference

12 December 2020

Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.

1 reference

12 December 2020

Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans

1 reference

12 December 2020

Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy

1 reference

12 December 2020

Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis.

1 reference

12 December 2020

In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.

1 reference

12 December 2020

In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans

1 reference

12 December 2020

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

1 reference

12 December 2020

Therapeutic outcome in invasive aspergillosis

1 reference

12 December 2020

Sordarins: A new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts

1 reference

12 December 2020

Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis

1 reference

12 December 2020

Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis

1 reference

12 December 2020

Successful treatment of fluconazole-resistant oropharyngeal candidiasis by a combination of fluconazole and terbinafine

1 reference

12 December 2020

Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephr

1 reference

12 December 2020

Antifungal Action of Amphotericin B in Combination with Other Polyene or Imidazole Antibiotics

1 reference

12 December 2020

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

1 reference

12 December 2020

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

1 reference

12 December 2020

Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis

1 reference

12 December 2020

Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (Nikkomycin Z) for inhibition and killing of fungal pathogens

1 reference

12 December 2020

Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis

1 reference

12 December 2020

In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis

1 reference

12 December 2020

In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.

1 reference

12 December 2020

Significance of antimicrobial synergism for the outcome of gram negative sepsis

1 reference

12 December 2020

Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.

1 reference

12 December 2020

Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis

1 reference

12 December 2020

A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients

1 reference

12 December 2020

Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis

1 reference

12 December 2020

Addition of caspofungin to fluconazole does not improve outcome in murine candidiasis

1 reference

12 December 2020

Mechanisms of synergistic interactions between amphotericin B and flucytosine

1 reference

12 December 2020

1 reference

12 December 2020

Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions

1 reference

12 December 2020

Susceptibility of Aspergillus to 5-fluorocytosine and amphotericin B alone and in combination

1 reference

12 December 2020

Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients

1 reference

12 December 2020

Antibiotics that inhibit fungal cell wall development

1 reference

12 December 2020

Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans

1 reference

12 December 2020

Combination therapy in experimental invasive aspergillosis

1 reference

12 December 2020

Synergism of Polyene Antibiotics with 5-Fluorocytosine

1 reference

12 December 2020

Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods

1 reference

12 December 2020

Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis

1 reference

12 December 2020

The search for synergy: a critical review from a response surface perspective.

1 reference

12 December 2020

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

1 reference

12 December 2020

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial

1 reference

12 December 2020

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

1 reference

12 December 2020

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)

1 reference

12 December 2020

Antagonistic interactions between azoles and amphotericin B with yeasts depend on azole lipophilia for special test conditions in vitro

1 reference

12 December 2020

Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome

1 reference

12 December 2020

Principles of combination therapy

1 reference

12 December 2020

Interactions between triazoles and amphotericin B against Cryptococcus neoformans

1 reference

12 December 2020

In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points

1 reference

12 December 2020

Candida glabrata infection after total hip arthroplasty

1 reference

12 December 2020

Combination antifungal therapy for invasive aspergillosis

1 reference

12 December 2020

Treatment of Experimental Cryptococcal Meningitis with Amphotericin B, 5-Fluorocytosine, and Ketoconazole

1 reference

12 December 2020

Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro

1 reference

12 December 2020

Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis

1 reference

12 December 2020

Antifungal Action of Rifampin

1 reference

12 December 2020

Synergistic Action of Amphotericin Band Rifampin against Candida Species

1 reference

12 December 2020

Effects of antifungal agent combinations administered simultaneously and sequentially against Aspergillus fumigatus

1 reference

12 December 2020

In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles

1 reference

12 December 2020

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

1 reference

12 December 2020

Interaction between azoles and amphotericin B in the treatment of candidiasis

1 reference

12 December 2020

Flucytosine monotherapy for cryptococcosis.

1 reference

12 December 2020

In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans

1 reference

12 December 2020

Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro

1 reference

12 December 2020

Combined Amphotericin B-Flucytosine Therapy in Aspergillus Pneumonia

1 reference

12 December 2020

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

1 reference

12 December 2020

Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.

1 reference

12 December 2020

Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species

1 reference

12 December 2020

Combined Activity of Amphotericin B and 5-Fluorocytosine against Cryptococcus neoformans in Vitro and in Vivo in Mice

1 reference

12 December 2020

Interactions of itraconazole with amphotericin B in the treatment of murine invasive candidiasis

1 reference

12 December 2020

Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS.

1 reference

12 December 2020

In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates ofCandida species

1 reference

12 December 2020

Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management

1 reference

12 December 2020

In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp

1 reference

12 December 2020

In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans

1 reference

12 December 2020

Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole

1 reference

12 December 2020

10.2165/00003495-200565110-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

12 August 2017

1046518735

0 references

Fatcat ID

release_slviobzts5c5rjjcgdggunx5mu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/slviobzts5c5rjjcgdggunx5mu

24 November 2022

mapped directly with Wikidata item

1 reference